Showing results (21-30 of 394) with videos related to

Sort By:
Pageof 40
Cell|January 28, 2021
Strength in numbers: predicting response to checkpoint inhibitors from large clinical datasetsAlbrecht Stenzinger, Daniel Kazdal, Solange Peters
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 7, 2022
Beyond Checkpoint Inhibitors: Enhancing Antitumor Immune Response in Lung CancerRachel E Sanborn, Famke L Schneiders, Suresh Senan, et al.
Translational Lung Cancer Research|May 17, 2023
Adjuvant therapies in stages I-III epidermal growth factor receptor-mutated lung cancer: current and future perspectivesMark G Kris, Tetsuya Mitsudomi, Solange Peters
Cancer Discovery|April 3, 2021
Treatment Decisions for Patients with Cancer during the COVID-19 PandemicChris Labaki, Solange Peters, Toni K Choueiri
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2023
Antibody-Drug Conjugates in Lung Cancer: Recent Advances and Implementing StrategiesAntonio Passaro, Pasi A Jänne, Solange Peters
Cancer Treatment Reviews|July 17, 2014
Oral epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: comparative pharmacokinetics and drug-drug interactionsSolange Peters, Stefan Zimmermann, Alex A Adjei
Revue Medicale Suisse|December 18, 2015
[Is prescription of a therapy costing 150,000 CHF reasonable?]Solange Peters, Roger von Moos, Beat Thurlimann
Cancer Treatment Reviews|November 21, 2017
PD-1 blockade in advanced NSCLC: A focus on pembrolizumabSolange Peters, Keith M Kerr, Rolf Stahel
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|July 20, 2017
Feasibility of advanced practice nursing in lung cancer consultations during early treatment: A phase II studyAndrea Serena, Andrew Dwyer, Solange Peters, et al.
Cancer Treatment Reviews|March 29, 2016
The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancerSolange Peters, Christin Bexelius, Veronica Munk, et al.
Pageof 40